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assay (ELISA) kits (IBEX & Nordic Bioscience). Relationships between
ratios of degradation to synthesis markers and JSW-D were evaluated
using analysis of covariance (ANCOVA).
Results: All data were all transformed (via square root or natural log)
to normalize distributions. Covariates including baseline age, sex, BMI,
and time since baseline evaluation were retained in ANCOVA models if
they were found to have p-values >0.2. Transformed mean & median
concentrations as well as p-values for degradation to synthesis ratios are
presented in Table 1.
Conclusions: Degradation to synthesis of uC1,2C/sCPII and uCTX-II/sCPII
were found to be signiﬁcantly different in ACL-R subjects at 1 & 4 year
follow-up intervals compared to healthy control values. uC2C/sCPII ratio
values, however, were not signiﬁcantly different than control values.
Although both uC2C and uC1,2C detect similar epitopes of type-II collagen
degradation, uC1,2C also detects a neoepitope produced by the cleavage
of type-I collagen. It may be that the earliest changes following ACL-R
as detected by this assay are related to bone turnover. These markers,
evaluated in ratio, were not able to discriminate between ACL-R subjects
with JSW’s falling in or out of the normal JSW range.
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CHEMOKINES AS SERUM BIOMARKERS IN DIFFERENT STAGES OF
OA PATIENTS
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Hosp. of Sun Yat-sen Univ., Guangzhou, China; 2Washington Unversity Sch.
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Purpose: Osteoarthritis (OA), as a joint degenerative disease, is one of
the most common musculoskeletal disorder world-wide. OA biomarker
is important to predict and measure the progression and outcomes, but
few, such biomarkers have been used for this purpose.
IL-1b and the adipokine, Resistin which is present in synovial joints after
injury, are important cytokines in rheumatoid and osteoarthritic joint
diseases by highly stimulating other proinﬂammatory cytokines and
chemokines. Cytokines and chemokines are mediators of inﬂammation
and are known to be important in inﬂammatory diseases, including RA
and OA. As we reported, CCL3, CCL4, CXCL2, and CXCL8 (IL-8) are highly
expressed in human articular chondrocytes by stimulation.
In present study, we focused on serum levels of CCL3, CCL4, CXCL2, CXCL8
(IL-8), IL-6, IL-1b, white blood cell (WBC), erythrocyte sedimentation rate
(ESR) and C reactive protein (CRP), in healthy adults and patients with
different stages OA.
Methods: Using ELISA with related antibodies and cell counter, we
compare serum levels of CCL3, CCL4, CXCL2, IL-8, IL-6, IL-1b, WBC, ESR
and CRP in 4 patients with medial OA (1 woman and 3 men; mean age:
58.25±4.03 yr), 5 patients with severe OA (4 women and 1 man; mean
age: 62.4±12.62 yr), and 4 healthy controls (1 woman and 3 men; mean
age: 26±9.9 yr) (IRB: 2011029). For different stage OA, medial OA was
with persistent (>3 months) pain in one or both knees without any injury
and deﬁnite X-ray no siginiﬁcant evidence of OA in both knee, which
was clinical diagnosised as OA and going to do arthroscopy; severe OA
was with persistent (>3 months) pain in one or both knees and deﬁnite
X-ray evidence of OA in one or both knee, which was going to do joint
replacement.
Fig. 1. The relative fold change of CCL3, CCL4, CXCL2, IL-8, IL-6, IL-1b,
WBC, and ESR in serum level of healthy adults, early stage OA patients
and late stage OA patients.
Fig. 2. The concentration of CXCL2, IL-8, CCL3, CCL4, IL-6, IL-1b in
serum level of healthy adults, early stage OA patients and late stage
OA patients.
Results: CCL3, CCL4, CXCL2, IL-8 and IL-1b were gradually increased
in serum levels of healthy adults, early stage OA patients and late
stage OA patients (Figure 1 and 2). WBC and CRP were not signiﬁcant
changed during different stages of OA patients (Figure 1). IL-6 and ESR
were no difference between normal adults and medial OA patients,
but they were signiﬁcant increased in severe OA patients (Figure 1).
The concentration of CXCL2 and IL-8 in serum were over 100ng/L in
normal adults, and they were increased in medial OA patients (CXCL2,
203.89±11.57ng/l; IL-8, 154.63±9.33ng/l) and severe OA patients (CXCL2,
246.26±7.92ng/l; IL-8, 174.05±5.33ng/l) (Figure 2A). The concentration
Poster Presentations / Osteoarthritis and Cartilage 19S1 (2011) S53–S236 S75
of CCL3 and CCL4 were over 21ng/L in normal adults, which were much
higher than IL-6 and IL-1b (Figure 2B). The concentration of CCL3 was
36.34±2.68ng/l, 55.30±4.05ng/l, and 62.56±2.39ng/l in normal adults,
medial OA patients, and severe OA patients (Figure 2B). The ratio of
CCL4 was signiﬁcant different in normal adults and different stages
of OA patients (Figure 1), and the concentration was 21.75±4.80ng/l,
43.80±4.27ng/l, and 60.50±5.87ng/l (Figure 2B).
Conclusion: CCL3, CCL4, CXCL2, IL-8 and IL-1b could be serum
biomarkers to identify healthy adults, early stage OA patients and late
stage OA patients from our primary data, especially CCL4 and CXCL2
were detectable and useful.
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FIBULIN-3 FRAGMENTS (FIB3–1 AND FIB3–2) ARE POTENTIAL NEW
BIOMARKERS FOR THE DIAGNOSIS OF OSTEOARTHRITIS
Y. Henrotin1, M. Gharbi2, M. Deberg2, J-E. Dubuc3, E. De Pauw1. 1Univ.
of Liege, Liege, Belgium; 2Artialis SA, Liege, Belgium; 3Cliniques Univ.ires St
Luc, Bruxelles, Belgium
Purpose: Fibulin-3 is a member of the ﬁbulin family protein, newly
recognized as extracellular matrix protein that negatively regulates
chondrocyte differentiation. Using tandem mass spectrometry, we have
found elevated levels of two fragments of ﬁbulin-3 (Fib3–1 and Fib3–2)
in the urine OA patients compared to those of healthy or osteoporotic
subjects. The aim of this study was to measure Fib3–1 and Fib3–2 in
serum of healthy subjects and osteoarthritic (OA) patients using two
speciﬁc immunoassays.
Methods: Sera were collected from 236 healthy ambulatory subjects
(93 women, 143 men) aged from 20 to 64 years (mean ± SD: 43.8±11.7)
and attending a blood donor center and from 39 patients aged from 39
to 82 years (mean ± SD: 68.4±11.1) with knee OA (29 women, 10 men)
diagnosed according to the ACR clinical and radiological criteria. None
of the healthy subjects had histories of OA or current OA symptoms
and none of them were subjected to joint radiography or other imaging
assessment. Two rabbit antisera, AS88 and AS94, with a high speciﬁcity
for Fib3–1 and Fib3–2, respectively were produced and used to develop
speciﬁc immunoassays. The lower detection limit of the assays was
5.2 pM for Fib3–1 and 8 pM for Fib3–2 and the working range of
concentration was comprised between 12.5 pM and 400 pM. Antisera
did not recognize native ﬁbuline-3 and did not cross-react with each
fragment.
Results: Immunostaining revealed the extensive presence of Fib3–1 and
Fib3–2 in the chondrocytes and extracellular matrix of the superﬁcial
layer of the ﬁbrillated cartilage. The median concentrations of Fib3–1 and
Fib3–2 in sera of healthy subjects were 58.5 pM (25%-75% range 46.2–
73.9 pM) and 140.8 pM (25%-75% range 126.5–156.3 pM), respectively.
Fib3–1, but not Fib3–2, was confounded by age and gender. By
comparison with age-matched healthy subjects, Fib3–1 (median, 54.6
pM vs 71.1 pM; p < 0.01) and Fib3–2 (median, 144.4 pM vs 183.0 pM;
p < 0.0001) serum levels were elevated in OA patients. No correlation was
found between Fib3–1 and Fib3–2 serum levels, suggesting that these
biomarkers reﬂect different aspects of the disease.
Conclusions: By comparison with healthy subjects, Fib3–1 and FiB3–2
serum levels are found elevated in patients with knee OA. Furthermore,
the immunohistochemical ﬁndings indicate that ﬁbrillated cartilage is a
major source of ﬁbulin-3 fragments. Fib3–1 and Fib3–2 are considered
as promising biochemical markers for the diagnosis of OA.
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DIAGNOSIS OF OSTEOARTHRITIS BY QUANTIFICATION OF TIBIA
TRABECULAR BONE STRUCTURE FROM MAGNETIC RESONANCE
IMAGING
J. Marques1,2, E. Dam2. 1Univ. of Copenhagen, Copenhagen, Denmark;
2BiomedIQ S/A, Rødovre, Denmark
Purpose: Magnetic resonance imaging (MRI) has helped experts to
diagnose Osteoarthritis (OA) by detecting early tissue changes. Current
semi quantitative measures of the whole knee joint cover various
structures within the joint, for example, the whole-organ MRI score
(WORMS), the Knee Osteoarthritis Scoring System (KOSS) and the Boston-
Leeds Osteoarthritis Knee Score (BLOKS). Focusing on bone quality, to
the authors’ knowledge, only semi-automatic quantitative method exists
for quantifying knee trabecular structure in MRI. We investigated the
possibility of detecting OA by a fully automatic method analyzing the
trabecular structure of the tibia bone.
Methods: The data consisted of 313 knee MRI from a community-based,
non-treatment study with 159 subjects. The population characteristics
were: age 56±16, Body Mass Index 26±4, 47% female, and 19% with
radiographic OA (Kellgren Lawrence grade, KLG > 1). The KLG was
determined from load-bearing radiographs in semi-ﬂexed position using
the SynaFlex (Synarc). MRI scans were acquired using a Turbo 3D T1
sequence from a 0.18T Esaote scanner (40° FA, TR 50ms, TE 16ms, scan
time 10 minutes, resolution 0.7mm×0.7mm×0.8mm).
To quantify the bone structure, initially a voxel classiﬁcation method
determines a region-of-interest (ROI) by segmenting the tibia bone and
from there extracting the trabecular bone. Figure 1 shows the segmented
tibia bone in light gray and the ROI in light green. From the ROI, a generic
set of 534 features is extracted by applying Gaussian derivatives at
multiple scales. The process captures the differential geometry structure
of the local intensities, allowing analyze the intricate network of the
trabecular bone anatomy.
At next step, a machine learning approach applies partial least squares
feature extraction to identify the linear combination of the features that
best discriminate the disease. The features extracted are employed to
train the linear classiﬁer to recognize the trabecular bone of a knee with
OA. Using cross-validation, the bone structure marker estimates for each
knee the classiﬁed probability of having OA.
Fig. 1.
Results: The resulting marker was analyzed for the ability to separate
OA (KLG > 1) and healthy knees. The median area under the receiver-
operator characteristics curve was 0.91 (p < 0.0001). Figure 2 shows the
cross-sectional separation.
Fig. 2.
Conclusions: The investigation revealed that disease-related bone
structure characteristics were reﬂected in the low-ﬁeld MRI appearance.
The applied texture analysis captured tissue changes and provided
insights into OA diagnosis. Even though the individual trabeculae are not
visible, the outcome of our investigation demonstrated the possibility
of analyzing the intricate network of the trabecular bone as a whole
